Narcissus and Daffodil

Pharmacology of Narcissus compounds 351
Cozanitis, D.A., Dessypris, A. and Nuutila, K. (1980) The effect of galanthamine hydrobromide
on plasma ACTH in patients undergoing anaesthesia and surgery. Acta Anaethesia
Scandinavica, 24 (3), 166–168.
Cozanitis, D.A., Friedmann, T. and Furst, S. (1983) Study of the analgesic effects of galanthamine,
a cholinesterase inhibitor. Archives of Internal Pharmacodynamics and Therapeutics,
226 (2), 229–238.
Cozanitis, D.A., Halttunen, P. and Edgren, J. (1972) A cinebronchographic study demonstrating
the effect of galanthamine hydrobromide on conscious asthmatic volunteers.
Der Anaesthesist, 21 (2), 63–66.
Cozanitis , D.A., Nuuttila, K., Karhunew, P. and Baraka, A. (1973a) Changes in cardiac
rhythm with galanthamine hydrobromide. Der Anaesthesist, 22 (10), 457–459.
Cozanitis, D.A. and Toivakka, E. (1971) A comparative study of galanthamine hydrobromide
and atropine/neostigmine in conscious volunteers. Der Anaesthesist, 20, 416–421.
Cozanitis, D.A. and Toivakka, E. (1974) Treatment of respiratory depression with the anticholinesterase
drug galanthamine hydrobromide. Anaesthesia, 29 (5), 581–584.
Cozantis, D.A. and Toivakka, E. (1991) A comparative study of galanthamine hydrobromide
and atropine/neostigmine in conscious volunteers. Der Anaesthesist, 20, 416–421.
Cozanitis, D., Toivakka, E. and Dessypris, A. (1973b) Electroencephalographic and blood
chemistry responses to galanthamine hydrobromide in epileptic volunteers. Der Anaesthesist,
21, 457–459.
Cozanitis, D.A., Van de Pol, F., Wezel, H. and Crul, J.F. (1981) Antagonistic activity of
galanthamine on constant infusion of pancuronium in rats. Experientia, 37, 1326–1327.
Dal-Bianco, P., Maly, J., Wober, C., Lind, C., Koch, G., Hufgard, J., Marschall, I., Mraz, M.
and Deecke, L. (1991) Galanthamine treatment in Alzheimer’s disease. Journal of Neural
Transmission, 33, suppl., 59–63.
De Angelis, J. and Walts, L.F. (1972) Comparison of galanthamine with neostigmine for reversal
of d-tubocurarine neuromuscular blockade in man. Anesthesia and Analgesia, 51, 196–198.
Fishkin, R.J., Ince, E.S. and Carlezon, W.A. (1993) D-cycloserine attenuates scopolamineinduced
learning and memory deficits in rats. Behavioral and Neural Biology, 59, 150–157.
Friess, S.L., Durant, R.C., Whitcomb, E.R., Reber, L.J. and Thommsen, W.C. (1961) Some
toxicological properties of the alkaloids galanthamine and secrinine. Toxicology and
Applied Pharmacology, 3, 347–457.
Furusawa, E., and Furusawa, S. (1983) Therapeutic activity of pretazettine, standard drugs
and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice.
Chemotherapy, 29, 294–302.
Furusawa, E. and Furusawa, S. (1986) Therapeutic potentials of pretazettine, standard anticancer
drugs and combinations on subcutaneously implanted Lewis lung carcinoma.
Chemotherapy, 32 (6), 521–529.
Furusawa, E. and Furusawa, S. (1988) Effect of pretazettine and viva-natural, a dietary
seaweed extract, on spontaneous AKR leukaemia in comparison with standard drugs.
Oncology, 45 (3), 180–186.
Furusawa, E., Furusawa, S., Tani, S., Irie, H., Ktamura, K. and Widman, W.C. (1976a) Isolation
of pretazettine from Narcissus tazetta L. Chemical and Pharmaceutical Bulletin Tokyo, 24, 336–338.
Furusawa, E., Furusawa, S., Lee, J.Y.B. and Patanavanich, S. (1976b) Therapeutic activity of
pretazettine, a narcissus alkaloid, on Rauscher leukaemia: comparison with tazettine and
streptonigrin. Proceedings of the Society of Experimental Biology and Medicine, 152 (2), 186–191.
Furusawa, E., Lockwood, R.H., Furusawa, S., Lum, M.K.M. and Lee, J.Y.B. (1979) Therapeutic
activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukaemia.
Chemotherapy, 25 (5), 308–315.
Furusawa, E., Lum, M.K.M. and Furusawa, S. (1978) Therapeutic activity of pretazettine on
rauscher leukaemia: combination of antiviral activity and cellular protein inhibition.
Chemotherapy, 24, 259–266.